Testing effectiveness (Phase 2)UnknownNCT00986557
What this trial is testing
T-Lymphocyte Infusion or Standard Therapy in Treating Patients at Risk of Cytomegalovirus Infection After a Donor Stem Cell Transplant
Who this might be right for
Graft Versus Host DiseaseNonneoplastic Condition
University Hospital Birmingham 78